Excellent quarterly result. I wasn't expecting such a strong sales result for Q3 so the full year is looking very promising. Costs and other metrics seem to be well managed so just a matter of time before we see fundamentals push this one up to where it should be.
Ann: Quarterly Activities & Cashflow Report, page-2
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.010(2.78%) |
Mkt cap ! $78.74M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $212.1K | 567.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1612 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 19642 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
37.0¢ |
Change
0.010 ( 0.57 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.0¢ | 36.5¢ | 165056 | ||
| Last updated 15.55pm 14/06/2024 ? | |||||
| BIO (ASX) Chart |